[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-inflammatory-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-inflammatory-disease":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,54],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":35,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100388150","deployment-o-the-multidisciplinary-prospective-cohort-imminent-100388150",false,"NCT04334031","Deployment o the Multidisciplinary Prospective Cohort Imminent","IMMINeNT","Inclusion Criteria:\n\n* Patient followed for their IMID in one of the departments of the Lille University Hospital participating in the study (dermatology, internal medicine, neurology, pneumology and rheumatology)\n* Social insured\n* Have the capacity to understand the study requirements, provide written informed consent, and comply with the study data collection procedures.\n\nExclusion Criteria:\n\n* Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of coverage by the social security system.\n* Pregnant or breastfeeding woman\n* Persons deprived of liberty\n* Protected minors or adults\n* Persons who have refused or are incapable of giving informed consent\n* Persons in Emergency Situations","ALL","18 Years",{"count":19,"type":20},2200,"ESTIMATED","INTERVENTIONAL",[23],"NA","Immune-mediated inflammatory diseases (IMIDs) most often affect young patients and have high impact on morbidity and mortality with a significant alteration in the quality of life of patients with professional, social and emotional repercussions.\n\nBeyond this burden, IMIDs share many common pathophysiological mechanisms and treatments, known as \"targeted therapies\". Despite progress in this field, much remains to be done in clinical, therapeutic and fundamental research to address the efficacy, resistance and side-effects of treatment.\n\nThese similarities between IMIDs have led the FHU IMMINeNT to propose the creation of a prospective, multidisciplinary clinical-biological database (IMMINeNT cohort), associated to a biobank, of patients with IMIDs. The main objectives of this database will be to identify new prognostic and therapeutic biomarkers in order to develop new therapeutic targets and biomarkers, to identify prognostic factors and determinants related to the activity, severity and quality of life of patients with IMIDs as well as to the response and tolerance to treatment.",[26,27,28,29,30,31,32,33,34],"Chronic Inflammatory Disease","Angioedema","Severe Asthma","Lupus","Atopic Dermatitis","Psoriatic Arthritis","Multiple Sclerosis","Systemic Sclerosis","Behçet Disease",[36,37,38,39,40],"Immune Mediated Inflammatory Diseases (IMIDs)","biomarker","cohort study","quality of life","disease severity","RECRUITING","2026-04-28",{"date":44,"type":45},"2026-05-05","ACTUAL",{"date":47,"type":45},"2020-07-20",{"date":49,"type":20},"2031-07-21",{"name":51,"class":52},"University Hospital, Lille","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":62,"targetDuration":4,"studyType":64,"phases":4,"briefSummary":65,"conditions":66,"keywords":67,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":53},"100563792","impact-of-the-therapeutic-education-program-living-with-a-chronic-inflammatory-disease-under-biotherapy-on-patient-compliance-and-quality-of-life-100563792","NCT06620770","Impact of the Therapeutic Education Program \"living with a Chronic Inflammatory Disease Under Biotherapy\" on Patient Compliance and Quality of Life","Impact of the Therapeutic Education Program \"living with Chronic Inflammatory Disease Under Biotherapy\" on Compliance and Quality of Life of Patients","IMPEBIO","Inclusion Criteria:\n\n* All major patients followed up on GHBS for chronic inflammatory disease treated with S\u002FC biotherapy.\n* Patients not opposed to their participation in the research.\n* Less than 3 months between inclusion and start of Therapeutic Education Program.\n\nExclusion Criteria:\n\n* Subcutaneous injection by another person.\n* Patients with cognitive impairment.\n* Persons of legal age who are the subject of a legal protection (safeguarding of justice, curatorship, guardianship), persons deprived of liberty.\n* Pregnant women.\n* Persons not covered by social security.",{"count":63,"type":20},126,"OBSERVATIONAL","Patient therapeutic education programs have been shown to be effective in many specialties, allowing \"Improving biological and psychological parameters, allowing patients to improve their health knowledge, therapeutic adherence and sense of personal effectiveness.\" Several studies have shown that patient knowledge, adherence and satisfaction are better after attending a therapeutic education program.\n\nThis multidisciplinary program is presented and offered to all patients with chronic disease treated by subcutaneous biotherapy, followed by dermatologists, rheumatologists and gastroenterologists of the Lorient hospital.\n\nThe study aims to demonstrate the benefit of the Patient Therapeutic Education program at GHBS Lorient \"living with a chronic inflammatory disease under biotherapy\" on treatment adherence, as well as the positive impact on quality of life.",[26],[68,69],"Biotherapy","Therapeutic education program","2025-03-13",{"date":72,"type":45},"2025-03-14",{"date":74,"type":45},"2025-02-14",{"date":76,"type":20},"2028-03",{"name":78,"class":52},"Groupe Hospitalier de Bretagne Sud"]